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Abstract
Background Cellular grafts used for skin repair require rapid integration with the host tissue to remain viable and
especially to nourish the epidermal cells. Here, we evaluated the responses in the split-thickness skin grafts (STSGs)
grafted on three differently treated wound beds: directly on excised wound bed (EX), on an artificial dermal template
(DT) and on granulation tissue (GT) induced by cellulose sponge.
Methods In ten burn patients, after excision, a test area was divided into three sections: One transplanted with STSG
instantaneously and two sections had a pre-treatment for 2 weeks with either DT or a cellulose sponge inducing
granulation tissue formation and thereafter grafted with STSGs.
Results One week after grafting, the STSGs on GT demonstrated most endothelial CD31? staining, largest average
vessel diameters as well as most CD163? staining of M2-like macrophages and most MIB1? proliferating epidermal
cells, suggesting an active regenerative environment. STSGs on DT had smallest vessel diameters and the least
CD163? macrophages. STSGs on EX had the least CD31? cells and the least MIB1? proliferating cells. After
3 months, this reactivity in STSGs had subsided, except increased dermal cell proliferation was observed in STSGs
on EX.
Conclusions Results show that pre-treatment of wound bed and induction of granulation tissue formation can
accelerate host–graft interaction by stimulating graft vasculature and inducing cell proliferation.
Introduction
Transplantation of split-thickness skin grafts (STSGs) is
routinely used in the surgical treatment of both acute and
chronic wounds. As a drawback, STSGs may not deliver
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enough dermal support for optimal host–graft interaction
kinetics. Therefore, either temporary wound covers to
induce formation of granulation tissue as the basis of new
dermis or permanent dermal substitutes that introduce a
novel dermis are often used. Temporary wound covers like
cadaver skin, xenografts, allogeneic keratinocytes, syn-
thetic membranes or different wound care products help to
protect the wound [1] and to induce granulation tissue
formation prior to grafting. Viscose cellulose sponges have
been used as temporary wound covers to stimulate granu-
lation tissue formation in, e.g., deep burns and traumatic
injuries [2, 3]. Permanent skin substitutes, on the other
hand, replace either the dermis, epidermis or both, and the
dermal substitutes offer a biodegradable support to assist
STSG engraftment. These materials usually consist of
matrix components with or without dermal and/or epider-
mal cells [4]. A widely used artificial dermal template
(DT), Integra, made of type I collagen and chondroitin-6-
sulfate, has a matrix that facilitates the migration of
fibroblasts and endothelial cells and therefore an ingrowth
of new vessels into the material.
If, for example, the lack of available donor sites delays
skin grafting, time should be used for priming the wound bed.
Once grafting can be carried out, a primed wound bed can
better promote the graft’s take and support its integration. So
far, mostly animal models have been used for studies
investigating recipient site priming [5, 6]. These works have
identified that wound bed vascularization is crucial for sur-
vival of epidermal cell layers and for re-establishing or
maintaining a permanent barrier for fluids and microbes
[7, 8]. Both the quality and the quantity of neodermis or
granulation tissue [9] are critical to wound healing. On the
other hand, overgrowth of vascularized and collagenous
granulation tissue has been associated with bad scar quality
[10, 11]. Thus, a well-primed wound bed with healthy
granulation tissue or an active dermal substitute can crucially
affect the outcome of skin replacement.
In this study, we investigated three wound bed priming
strategies on their early effect on STSGs in patients with
large full-thickness burns. The wound beds were (1)
unprimed with an STSG grafted instantly after the excision,
(2) primed with a permanent artificial dermal substitute or
(3) primed with a viscose cellulose sponge to induce
granulation tissue formation. Histological analyses were
carried out from wound biopsies taken at 1-week and
3-month time points after transplantation of STSGs
(Fig. 1). Graft vascularization was evaluated by CD31
endothelial cell staining and diameter of CD31? vascular
structures. The amount of M2-like regeneration-associated
macrophages in STSGs was evaluated with CD163 stain-
ing. Our results provide the first insight into the graft
response kinetics after host site priming in a clinically
relevant setting [12].
Materials and methods
Patients
Ten adult patients (age range 19–58, mean 36.8 ± 4.0 years)
with large deep burns consecutively admitted to Helsinki Burn
Centre were included in the study. Total burned surface areas
(TBSAs) ranged from 22 to 45% (mean 35.8 ± 2.4%). Patient
demographics and the location of test areas are presented in
Table 1. The study was approved by Research Ethics Com-
mittee of the Helsinki University Hospital (DNro 101/E6/
2000), and informed consent was obtained from all subjects.
Wounds and wound bed treatments
Test areas were located within an anterior deep third-degree
burn. Fascial wound excisions were performed 1–5 days
after injury. Three adjacent areas (each 10 9 5 cm) were
covered with: (1) a STSG instantly, (2) an artificial dermal
template (Integra) and (3) a viscose cellulose sponge
(CellonexTM, Vivoxid Ltd, Finland) in random order.
Wound beds of sections 2 and 3 were primed for 2 weeks
before transplantation of STSGs. Figures 2, 3 show the
study timeline, Fig. 2 illustrating the wound beds before and
after treatments. The burn wounds surrounding the test sites
were covered with meshed autografts. A monofilament
polyamide woven dressing (Surfasoft, Mediprof, Bleis-
wijk, The Netherlands) and saline gauzes were used to cover
the materials and the autografts. Topical antibiotics or silver
was not used at test site or its immediate proximity.
All STSGs were harvested with a dermatome (Zimmer
Inc, Warsaw, IN, USA). The 8/1000-in.-thick non-meshed
grafts included epidermis, basement membrane and the
superficial part of the dermis.
The DT used in this study has a biodegradable two-layer
matrix with silicone providing protection against invasion of
microbes and loss of fluids until replaced by STSG. The lower
layer contains porous matrix of bovine tendon type I collagen
Table 1 Patient demographics, burn surface areas and test sites
Gender Age TBSA (%) Test location
Male 32 45 Chest/abdomen
Male 19 22 Chest/abdomen
Male 39 30 Thigh
Female 58 43 Chest
Male 54 40 Chest
Male 37 39 Chest
Male 40 33 Chest
Male 25 27 Chest
Male 41 42 Chest/abdomen
Male 23 37 Thigh
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and chondroitin-6-sulfate (glycosaminoglycan) obtained from
shark’s cartilage. The porosity (mean pore diameter
30–120 lm) has been shown to facilitate the migration of
inflammatory cells, fibroblasts and endothelial cells and thus
promotes the ingrowth of new blood vessels into matrix [13].
The temporary wound cover used in this study was a
sponge-like viscose cellulose matrix supported by cotton
fibers. The viscose cellulose contains micropores with a
diameter 1–10 lm and macropores with a diameter
100–1000 lm. The rate of cell invasion and the formation of
new tissue have been stated to be rapid in cellulose sponge [14].
Tissue samples, immunohistochemical stainings
and analyses
Three-mm punch biopsies were taken as detailed in Fig. 4.
Samples were fixed in 10% buffered formalin and embedded
CONSORT 2010 Flow Diagram
Assessed for eligibility (n=11)
Excluded (n=1)
♦ Not meeting inclusion criteria (n=0)
♦ Declined to participate (n=0)
♦ Other reasons (n=1) patient died
Analysed  (n=10)
♦ Excluded from analysis (give reasons) (n=0)
♦ Lost to follow-up (give reasons) (n=0)
♦ Discontinued intervention (give reasons) 
(n=0)
Allocated to intervention (n=10)
♦ Received allocated intervention (n=10)
♦ Did not receive allocated intervention (give 
reasons) (n=0)
Allocation
Analysis
Follow-Up
Randomized (n=10)
Enrollment
Fig. 1 CONSORT 2010 flow diagram
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in paraffin. Sections were stained with antibodies against
CD31, MIB1 and CD163 as detailed before [12]. Serial
microscopic images from the areas of the STSGs were
obtained using 2009 magnification. The images were ana-
lyzed using Fiji ImageJ software [15]. In Fiji ImageJ anal-
yses, a user-defined macro was constructed to process all
images in a similar manner to enable comparisons. The
images were thresholded for stained pixels, and the amount
of positive pixels was measured. All non-tissue areas were
subtracted from the total area of the full image to gain the
tissue-positive area in each image. Results are expressed as
the proportion of immunostain-positive pixels divided by
total positive tissue area in each image.
In morphometric analysis of CD31? vessels, all CD31?
circular structures in an image were manually drawn and the
areas of the vessels were measured with the measure function.
The number of measurements was assigned as the total number
of vessels per image. Vessel density was calculated by dividing
the number of vessels by total tissue area in a given image.
More detailed description of the protocol is given in
Supplementary information.
Statistics
Two-sided Student’s T test was used to detect statistically
significant differences between treatment modalities at
1 week and 3 months after skin grafting. p values less than
0.05 were considered significant. Linear correlation
(Pearson) was calculated for CD163? macrophages and
Fig. 2 Timeline of the study at days 0–14. Panel a wound bed of the
test area after tangential excision. Before covering with STSG, the
wound bed showed a well-vascularized muscle underneath fascia at
day 0. Panel b one of the treatment areas was covered with a thin
STSG (missing on the left side in the picture). The other two
treatment areas were covered with CellonexTM and Integra the next
2 weeks. Panel c day 3 after operation and after removal of
CellonexTM. Panel d day 7 after operation and after removal of
CellonexTM. Panels e–f on day 14 after the operation the silicone
layer from Integra was removed (e) and replaced by a thin STSG (f).
At that point also the CellonexTM was removed (e) and the wound bed
was covered with a thin STSG (f)
Fig. 3 Timeline of the study from day 21 to the 1-year follow-up.
Panel a day 21 after the primary operation: 3 weeks after placement
of STSG on treatment area without priming and 1 week after
placement of STSG on Integra and CellonexTM treatment areas.
Panel b three months after primary operation. Panel c one year after
primary operation
984 World J Surg (2018) 42:981–991
123
CD31? endothelial cells. Statistical calculations were done
using GraphPad Prism 5.0 software.
Results and discussion
Vascularity of STSGs
Analysis of CD31? endothelial cells and vessel structures
in STSGs was performed at 1 week and 3 months after skin
grafting. At 1 week, STSGs on cellulose sponge-primed
sites with induced granulation tissue (GT) demonstrated
the most CD31? cells compared to STSGs both on DT and
on non-primed excised wound beds (EX) (Figs. 5a–c, 6a).
STSGs on EX had the least CD31? cells, but results
remained statistically insignificantly different from STSGs
on DT.
In order to gain insight into vascular reactivity, we
evaluated the amount of CD31? vessels and their cross-
sectional areas. STSGs on induced GT had the largest
vessels (Fig. 6b). Interestingly, STSGs on DT had the
smallest average vessel areas of the treatment areas. Vessel
density did not differ among groups, although STSGs on
induced GT demonstrated a nonsignificant average
increase as compared to other treatments (Fig. 6c). Taken
together, these results showed that 1 week after grafting
STSGs on induced GT had more CD31? endothelial cells
and larger vessels compared to STSGs on DT or on EX.
After 3 months, the initial vascular responses in STSGs
on GT had returned to same level as in STSGs both on DT
Fig. 4 Timeline of
transplantation of skin grafts
and taking the biopsies
World J Surg (2018) 42:981–991 985
123
and on EX, suggesting that the angioactive response was
acute and transient (Supplementary Fig. 1).
Monocyte–macrophages in STSGs
We utilized the CD163 macrophage marker for assessment
of macrophage involvement in and infiltration into STSGs
in response to wound priming. CD163 expression is asso-
ciated with an anti-inflammatory repair macrophage M2
phenotype [16–18]. We found that at 1 week after graft
transplantation STSGs on induced GT showed increased
expression of CD163 compared to STSGs on DT and on
EX (Figs. 5d–f, 7a). Amount of CD163? macrophages
correlated significantly with expression of CD31 in all
samples (Supplementary Fig. 2), suggesting that macro-
phages may play a role in the vascular response of STSGs.
Cell proliferation in STSGs
Cell proliferation was evaluated by positive nuclear stain-
ing to MIB1 antibody recognizing Ki-67 antigen [19]. At
1 week, STSGs on induced GT showed the highest number
of MIB1? cells, whereas MIB1 staining of STSGs on EX
was the lowest. Also the most proliferating cells in the
STSGs’ epidermal compartment were detected in samples
with induced GT (Figs. 5g–i, 7b). Although cells in the
STSGs’ dermal compartment proliferated less than in the
corresponding epidermis, a significant difference was
found in dermal cell proliferation of STSGs on induced GT
compared to STSGs on EX (Fig. 7c).
At 3-month time point after grafting, cellular prolifera-
tion in epidermis of STSGs decreased, and differences
observed after 1 week were absent (Fig. 8a). Dermal
compartment of STSGs on EX, however, now demon-
strated significantly higher numbers of proliferating cells as
compared to sites with pre-grafting priming (Figs. 8b, 9).
Fig. 5 Immunohistochemical stainings at 1 week after skin grafting. Panels a–c CD31, panels d–f CD163, panels g–i MIB1. Panels a, d, g are
from unprimed, panels b, e, h are from Integra-primed, c, f, i are from Cellonex-primed STSGs
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Discussion
Although wound bed inflammation, infection and vascu-
larity are clinically recognized predictors of graft take and
integration, not much is known about the effect of wound
bed priming on the graft’s well-being [20]. We present here
the first study, to our knowledge, to compare the effects of
three different pre-grafting priming treatments of deep burn
wounds excised to fascial level in a prospective controlled
study in man. The gross histological and clinical evalua-
tions as well as 1-year cosmetic and functional outcome
have been published earlier [12]. In this study, we focused
on histological evaluation of the different wound bed
priming treatments on autologous STSGs. We surgically
excised full-thickness burn wounds of ten consecutive
patients with severe burns. The excised wounds were
divided into three sections: one without priming, one
primed with permanent artificial dermal template and one
primed with temporary cellulose sponge, and the histo-
logical responses of STSGs on these sites at 1 week and
3 months after graft placement were studied.
In samples taken at the 1-week follow-up, we found a
clear difference between priming methods. STSGs on
recipient sites primed with cellulose sponges inducing GT
formation showed a significantly stronger vascular
response (increased number of CD31? cells and bigger
average vessel diameter) than those transplanted on non-
primed or artificial dermal template-primed sites. The
stronger vascular responsiveness coincided also with
higher proliferation rate of epidermal cells and increased
amount of CD163? macrophages in the dermis compared
to STSGs on other test sites. This reactive response was
transient and had subsided at 3 months. Our results
underscore the importance of wound bed priming for pro-
moting early host–graft interactions and integration. This
wound bed priming method could be useful in situations
where areas of poor vascularization cannot be grafted, due
to any reason. Inducing well-vascularized granulation tis-
sue formation enables graft take avoiding unnecessary graft
loss or complicated reconstruction operations. On the other
hand, wound bed priming for the sake of priming alone
may result in delayed grafting operation, longer stay in
hospital with increased costs as well as longer period of
bFig. 6 CD31 staining of endothelial cells in STSGs 1 week after
transplantation a CD31? staining area counted as percentage of the
total STSG area. **represents p\0.01 of STSG on EX versus STSG
on GT, represents p\0.05 of STSG on DT versus STSG on GT,
b the average size of vessels was counted from the total area inside
the CD31? staining circular structures in pixels by dividing it by the
number of identified circular vessel structures. *represents p\0.05 of
STSG on EX versus STSG on GT, represents p\0.05 of STSG on
DT versus STSG on GT, c the density of vessels (number of vessels/
tissue area in pixels)
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open wounds with increased risk of infection and loss of
fluids. The cellular phase of wound healing is characterized
by initiation of an inflammatory response. Macrophages
have been shown to play a key role in orchestrating both
the quality of the inflammatory response and progression of
wound healing to the proliferation phase [21]. They
actively provide signals that control granulation tissue
formation and maturation, stabilize vascular structures and
guide myofibroblast differentiation [21]. Macrophages can
differentiate into various phenotypes with distinct func-
tions. The classically activated macrophages (M1) show
proinflammatory activities, whereas alternatively activated
tissue remodeling/profibrotic macrophages (M2) partici-
pate in angiogenesis, connective tissue remodeling and
resolution of inflammation [21, 22]. The M2 macrophages
can be further classified into subdivisions M2a, M2b, M2c
and M2d according to stimuli of activation and achieved
transcriptional changes [23]. The M2a and M2c subtypes,
Fig. 7 One week after transplantation of STSGs on different
treatment areas. a Monocyte–macrophages stained with CD163:
*represents p\0.05 of STSG on EX versus STSG on DT, 
represents p\0.001 of STSG on EX versus STSG on GT,
b proliferation of epidermal cells detected by MIB1 staining,
***represents p\0.001 of STSG on EX versus STSG on GT
and represents p\0.001 of STSG on DT versus STSG on GT,
c proliferation of dermal cells measured in percentage of MIB1?
staining area of the STSG’s dermal area, *represents p\0.05 of
STSG on EX versus STSG on GT
Fig. 8 Cell proliferation 3 months after operation in STSGs on
different treatment areas stained with MIB1. a In the epidermis of the
STSGs, b in the dermis of the STSGs, ***represents p\0.001 of
STSG on EX versus STSG on DT and **represents p\0.01 of STSG
on EX versus STSG on GT
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which are typically considered to promote angiogenesis
and tissue regeneration, express the membrane protein type
I CD163 antigen.
Our results showed that at 1 week after transplantation
the STSGs on GT showed the highest numbers of CD163?
macrophages of treatment sections. In fact, the viscose
cellulose sponge used in the study to induce granulation
tissue formation is known to attract inflammatory cells at
site [24, 25]. On the other hand, chondroitin sulfate, a
constituent of the artificial dermal template used in this
study, harbors anti-inflammatory properties and has been
shown to decrease the influx of inflammatory cells in, for
example, synovial inflammation [26]. In our study, the
highest numbers of CD163? macrophages coincided and
correlated with the highest CD31? average area and also
the highest numbers of MIB1? proliferating cells in STSGs
on GT of all STSGs. Taken together with previous reports
in other biological systems, our results that place the
CD163? macrophages in context with increased angio-
genesis and cellular proliferation in human skin suggest a
role for the M2 macrophages as active first-line modulators
of the early wound environment.
New vessels allow passage for more cells of the immune
system to enter the wound [27, 28] and contribute to the
microenvironmental signaling [29, 30]. Based on animal
studies, the kinetics of re- or neovascularization process of
a skin graft [6, 20] has been described as follows: In the
very early phase, graft survival depends on imbibition,
fluid absorption. Thereafter, the re-vascularization of a skin
graft proceeds in an ordered process: Vascular regression in
the graft is followed by vascular ingrowth from the recip-
ient wound bed, and connections between the vessels of the
host site and the graft (inosculation) appear. Typical
angiogenic changes, e.g., capillary widening, capillary bud
formation and an increase in the capillary density, are seen
both in wound bed and in skin graft [31]. We found that the
priming of the wound bed before skin grafting had an effect
on the size of blood vessels in STSGs 1 week after trans-
plantation. The STSGs on viscose cellulose sponge-treated
wound beds with induced GT showed more blood vessels
with larger average areas compared to the STSGs on other
test sites. Average area of the vessels was the lowest in
STSGs on DT. Thus, both CD31 staining and the average
area of blood vessels correlated with amount of CD163?
macrophages 1 week after skin grafting. This further sug-
gests that pre-treatment with non-permanent viscose cel-
lulose sponge contributes to the early formation of highly
vascularized granulation tissue in both the wound bed and
the STSG.
In the epidermis of STSGs, the percentage of prolifer-
ating cells remained rather constant from 1 week to
3 months except in STSGs on induced GT. There, the
amount of proliferating epidermal cells was about threefold
compared to other STSGs 1 week after grafting, but
equaled out at 3 months. This may be due to both better
vascularization and more M2-type macrophages. Amount
of proliferating dermal cells instead decreased massively
down to approximately 1/8 from 1 week to 3 months in all
other STSGs than ones on excised wound bed. One week
after grafting, dermal cells proliferated least in STSGs on
excised wound bed, but on contrary to other treatment
sections the MIB1? staining areas in dermis kept rising till
3 months at which time point positively stained areas had
doubled. Reason for this is unclear and requires further
studies.
The cellular events in this study do not directly translate
into clinics. In our previous study with the same patient
population, we observed 1 year after the primary surgery
that all study areas were clinically similar with no signifi-
cant differences in Vancouver scar scale or in histological
assessments. This somewhat surprising result does not
mean that differences in cellular or molecular level did not
Fig. 9 Panel a STSG without priming. Panel b STSG on wound primed with Integra. Panel c STSG on wound primed with CellonexTM
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exist. The methods to assess the functional and esthetic as
well as histological outcomes were chosen to be able to
compare our results with those of the other groups.
Unfortunately, Vancouver scar scale is not an optimal tool,
but rather subjective and histological assessments are fairly
gross. How the cellular findings here affect the clinical
results cannot be concluded. An interesting thing is that the
study areas were on fascial level and it is possible that the
findings might have been different if the grafts had been
inserted more superficially, e.g., on fatty tissue. One year
might also be too early time point to assess ‘‘final’’ out-
comes since maturation of scars is still in progress.
Our group is now investigating possible differences
between the treatment modalities on more detailed manner
and at later time points also trying to refine the assessment
of the clinical outcomes more objective ways.
Conclusions
Our results demonstrate that pre-treatment of the wound
bed prior to skin grafting exerts significant early histolog-
ical effects on STSGs. Pre-treatment with a cellulose
sponge increased the size of vessels in STSGs as well as
the numbers of M2-type macrophages and proliferation of
keratinocytes, suggesting better early nourishment of skin
graft as compared to other materials.
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